Warby Parker (WRBY) Net Cash Flow Growth (3y) (2023 - 2026)
Warby Parker (WRBY) Net Cash Flow Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.12 Bn | 120.90 Bn | 1.96 Bn | -16.59% |
| 2 | Becton Dickinson | 44.89 Bn | 44.07 Bn | 2.15 Bn | -55.30% |
| 3 | Alcon | 33.06 Bn | 31.40 Bn | 1.53 Bn | 39.87% |
| 4 | Medline | 32.81 Bn | 30.58 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.44 Bn | 27.78 Bn | 890.98 Mn | 126.35% |
| 6 | West Pharmaceutical Services | 23.12 Bn | 22.68 Bn | 329.20 Mn | 2.16% |
| 7 | Solventum | 14.06 Bn | 13.50 Bn | 1.10 Bn | -159.90% |
| 8 | Cooper Companies | 13.87 Bn | 13.73 Bn | 735.40 Mn | 78.59% |
| 9 | Align Technology | 12.07 Bn | 11.01 Bn | 736.59 Mn | 36.49% |
| 10 | Warby Parker | 3.11 Bn | 2.82 Bn | 131.04 Mn | 37.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.59% |
| Dec 31, 2025 | -18.68% |
| Sep 30, 2025 | 21.85% |
| Jun 30, 2025 | 46.64% |
| Mar 31, 2025 | 34.19% |
| Dec 31, 2024 | 32.90% |
| Sep 30, 2024 | 31.10% |
| Jun 30, 2024 | 35.59% |
| Mar 31, 2024 | 30.07% |
| Dec 31, 2023 | -61.49% |